Researcher Profile

Maarten Leyssen

Publications

509

Citations

Co-Authors

Active Years

Publications

Open Access Journal Article The Lancet Global Health Nov 01, 2023

Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in infants: a phase 2, randomised, double-blind, active-controlled trial in Guinea and Sierra Leone

Edward Man-Lik Choi · Boris Lacarra · Muhammed O Afolabi · Boni Maxime Ale +282 more

10.1016/s2214-109x(23)00410-2 13 citations

Open Access Journal Article The Lancet Infectious Diseases Jan 01, 2022

Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: a randomised, double-blind, controlled trial

Muhammed O Afolabi · David Ishola · Daniela Manno · Babajide Keshinro +333 more

10.1016/s1473-3099(21)00128-6 80 citations

Open Access Journal Article PLoS Medicine Jan 11, 2022

Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in children and adolescents in Africa: A randomised, placebo-controlled, multicentre Phase II clinical trial

Zacchaeus Anywaine · Houreratou Barry · Omu Anzala · Gaudensia Mutua +19 more

10.1371/journal.pmed.1003865 56 citations

Open Access Journal Article Trials Jun 20, 2022

Safety, reactogenicity, and immunogenicity of a 2-dose Ebola vaccine regimen of Ad26.ZEBOV followed by MVA-BN-Filo in healthy adult pregnant women: study protocol for a phase 3 open-label randomized controlled trial

Etienne Karita · Julien Nyombayire · Rosine Ingabire · Amelia Mazzei +14 more

10.1186/s13063-022-06360-3 16 citations

Open Access Journal Article The Lancet Infectious Diseases Jan 01, 2022

Safety and long-term immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Sierra Leone: a combined open-label, non-randomised stage 1, and a randomised, double-blind, controlled stage 2 trial

David Ishola · Daniela Manno · Muhammed O Afolabi · Babajide Keshinro +327 more

10.1016/s1473-3099(21)00125-0 79 citations

Open Access Journal Article PLoS Medicine Oct 29, 2021

Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in healthy and HIV-infected adults: A randomised, placebo-controlled Phase II clinical trial in Africa

Houreratou Barry · Gaudensia Mutua · Hannah Kibuuka · Zacchaeus Anywaine +19 more

10.1371/journal.pmed.1003813 61 citations

Open Access Journal Article The Journal of Infectious Diseases Sep 29, 2016

A Randomized, Controlled, Observer-Blinded Phase 1 Study of the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine With or Without Alum Adjuvant

Joanne M. Langley · Naresh Aggarwal · Azhar Toma · Scott A. Halperin +6 more

10.1093/infdis/jiw453 54 citations

Journal Article Human Vaccines & Immunotherapeutics Jun 12, 2012

Clarification to Long-term anti-HBs antibody persistence and immune memory in children and adolescents who received routine childhood hepatitis B vaccination. Hum Vaccin Immunother 2012; 8:813-8

Ulrich Behre · Gerhard Bleckmann · Priya Diana Crasta · Maarten Leyssen +3 more

10.4161/hv.19898 24 citations

Open Access Journal Article Current Biology Jun 01, 2005

The Drosophila Fragile X Mental Retardation Protein Controls Actin Dynamics by Directly Regulating Profilin in the Brain

Simon P. Reeve · Laura Bassetto · Ginka K. Genova · Yelena Kleyner +3 more

10.1016/j.cub.2005.05.050 126 citations

Publication Timeline

2023

2022

2021

2016

2012

2005

Frequent Co-Authors

6×

5×

5×

5×

4×

4×

3×

3×

3×

3×